circ_0007385 served as competing endogenousRNAformiR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells

被引:51
作者
Ye, Yancheng [1 ]
Zhao, Liangcun [1 ]
Li, Qingke [2 ]
Xi, Caixia [3 ]
Li, Yinghong [4 ]
Li, Zhengguo [3 ]
机构
[1] Gansu Wuwei Tumor Hosp, Dept Pharm, Wuwei, Peoples R China
[2] Gansu Wuwei Tumor Hosp, Dept Lab Med, Wuwei, Peoples R China
[3] Gansu Wuwei Tumor Hosp, Dept Resp Med, Wuwei, Peoples R China
[4] Gansu Wuwei Tumor Hosp, Dept Integrated Tradit Chinese & Western Med, Wuwei, Peoples R China
关键词
circ_0007385; HMGB1; miR-519d-3p; NSCLC; CIRCULAR RNA; IN-VITRO; PROLIFERATION; SENSITIVITY; INHIBITION; BIOGENESIS; EXPRESSION; INCREASES; CARCINOMA; GROWTH;
D O I
10.1111/1759-7714.13527
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Circular RNAs (circRNAs) have been closely implicated in competing endogenous RNA (ceRNA) network among human cancers including non-small cell lung cancer (NSCLC). However, the role of most circRNAs in NSCLC remains to be determined. Here, we aimed to investigate the role of hsa_circ_0007385 (circ_0007385) in NSCLC cells. Methods Expression of hsa_circ_0007385 (circ_0007385), miRNA (miR)-519d-5p and high-mobility group box 1 (HMGB1) was measured by real-time quantitative PCR and western blotting. Functional experiments were evaluated by cell counting kit (CCK)-8, flow cytometry, fluorescein active caspase-3 staining kit, transwell assays, western blotting, and xenograft experiment. The relationship among circ_0007385,miR-519d-5p and HMGB1 was testified by dual-luciferase reporter assay. Kaplan-Meiersurvival curve identified overall survival in NSCLC patients. Results circ_0007385 expression was higher in NSCLC tissues and cell lines, and was associated with poor overall survival. Silencing circ_0007385 could suppress cell proliferation, migration and invasion in A549 and H1975 cells, as well as cisplatin (DDP) resistance. Moreover, circ_0007385 silence retarded tumor growth of A549 cells in vivo. Molecularly, there was a direct interaction between miR-519d-3p and either circ_0007385 or HMGB1; expression of miR-519d-3p was downregulated in NSCLC tumors in a circ_0007385-correlated manner, and circ_0007385 could indirectly regulate HMGB1 via miR-519d-3p. Functionally, both inhibiting miR-519d-3p and restoring HMGB1 could overturn the suppressive effect of circ_0007385 knockdown on cell proliferation, migration, invasion, and DDP resistance. Conclusions Collectively, circ_0007385 deletion could function anti-tumor role in NSCLC by suppressing malignant behaviors and DDP resistance in vitro and in vivo via circ_0007385/miR-519d-3p/HMGB1 axis. These outcomes might enhance our understanding of the molecular mechanisms underlying the malignant progression of NSCLC. Key pointsSignificant findings of the study circ_0007385 was upregulated in NSCLC tissues and cells, and was associated with poor overall survival. Silenced circ_0007385 suppressed NSCLC cell proliferation, migration, invasion, and DDP resistance in vitro, and tumor growth in vivo. circ_0007385 was upregulated in NSCLC tissues and cells, and was associated with poor overall survival. What this study adds miR-519d-3p could directly interact with circ_0007385 and HMGB1 in NSCLC cells. A promising circ_0007385/miR-519d-3p/HMGB1 regulatory pathway was determined in NSCLC cells.
引用
收藏
页码:2196 / 2208
页数:13
相关论文
共 50 条
[21]   MiR-654-3p targets SRC to suppress tumor growth in non-small cell lung cancer [J].
Pang, Min ;
Jiang, Yongjie ;
Huang, Yuyan ;
Ren, Bi ;
He, Liping ;
Jiang, Li .
CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (04) :157-163
[22]   hsa_circ_0077837 Alleviated the Malignancy of Non-Small Cell Lung Cancer by Regulating the miR-1178-3p/APITD1 Axis [J].
Xu, Shanlin ;
Jiang, Yanyan ;
Duan, Yaqian .
JOURNAL OF ONCOLOGY, 2022, 2022
[23]   Orai3-Mediates Cisplatin-Resistance in Non-Small Cell Lung Cancer Cells by Enriching Cancer Stem Cell Population through PI3K/AKT Pathway [J].
Abou Daya, Hiba ;
Kouba, Sana ;
Ouled-Haddou, Hakim ;
Benzerdjeb, Nazim ;
Telliez, Marie-Sophie ;
Dayen, Charles ;
Sevestre, Henri ;
Garcon, Loic ;
Hague, Frederic ;
Ouadid-Ahidouch, Halima .
CANCERS, 2021, 13 (10)
[24]   Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer [J].
Ma, Ying ;
Feng, Qin ;
Han, Bateer ;
Yu, Rong ;
Jin, Zhiyong .
HEREDITAS, 2023, 160 (01)
[25]   MicroRNA-29b-3p reduces cisplatin resistance in non-small cell lung cancer by targeting myeloid cell leukemia-1 [J].
Cheng, Yuanjun ;
Chen, Bin ;
Dong, Xuxiao ;
Shu, Jian ;
Yao, Jie .
MOLECULAR & CELLULAR TOXICOLOGY, 2025, 21 (01) :205-215
[26]   Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4 [J].
Fu, W. -F. ;
Chen, W. -B. ;
Dai, L. ;
Yang, G. -P. ;
Jiang, Z. -Y. ;
Pan, L. ;
Zhao, J. ;
Chen, G. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (12) :2565-2572
[27]   Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest [J].
Sarin, Navin ;
Engel, Florian ;
Kalayda, Ganna V. ;
Mannewitz, Mareike ;
Cinatl, Jindrich, Jr. ;
Rothweiler, Florian ;
Michaelis, Martin ;
Saafan, Hisham ;
Ritter, Christoph A. ;
Jaehde, Ulrich ;
Froetschl, Roland .
PLOS ONE, 2017, 12 (07)
[28]   Circ_0020123 Increases ZFX Expression to Facilitate Non-Small Cell Lung Cancer Progression by Sponging miR-142-3p [J].
Lu, Jiancong ;
Ma, Ximiao ;
Lin, Junhong ;
Hou, Peifeng .
CANCER MANAGEMENT AND RESEARCH, 2021, 13 :1687-1698
[29]   Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging [J].
Chen, Shuifang ;
Lu, Shan ;
Yao, Yinan ;
Chen, Junjun ;
Yang, Guangdie ;
Tu, Lingfang ;
Zhang, Zeying ;
Zhang, Jianli ;
Chen, Lina .
AGING-US, 2020, 12 (14) :14329-14340
[30]   Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis [J].
Chu, Dan ;
Li, Pengpeng ;
Li, Yameng ;
Shi, Jiang ;
Huang, Siyuan ;
Jiao, Pengfei .
THORACIC CANCER, 2021, 12 (21) :2894-2906